Discovery of 2-methyl-5-(1H-pyrazol-4-yl)pyridines and related heterocycles as promising M4 mAChR positive allosteric modulators for the treatment of neurocognitive disorders.
August 16, 2024
You are using an out of date browser. For the best experience on this site and added security, please update to a modern browser.
Update your browser